Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Polyethylenimine Linear (PEI, MW 40,000): Atomic Evidence...

    2025-12-31

    Polyethylenimine Linear (PEI, MW 40,000): Atomic Evidence & Optimized Use in DNA Transfection

    Executive Summary: Polyethylenimine Linear (PEI, MW 40,000) is a cationic polymer widely used as a serum-compatible DNA transfection reagent for in vitro research, supporting transient gene expression and recombinant protein production with typical efficiencies between 60% and 80% under standard conditions (APExBIO). Its mechanism involves electrostatic condensation of DNA and facilitation of endocytosis-mediated uptake (source). The reagent is validated across major cell lines (HEK-293, CHO-K1, HepG2, HeLa) and scales from microplate to bioreactor formats (source). This article compiles atomic, verifiable facts, clarifies performance boundaries, and updates best-practice guidelines for molecular biology workflows, extending evidence from prior reviews (source).

    Biological Rationale

    Efficient delivery of nucleic acids into mammalian cells is essential for genetic studies, recombinant protein production, and functional genomics. DNA is negatively charged and cannot efficiently cross the cell membrane unaided. Polyethylenimine Linear (PEI, MW 40,000) is a synthetic cationic polymer that condenses DNA into positively charged nanoparticles, increasing cellular uptake via endocytosis (Roach 2024). Linear PEI variants are preferred for reduced cytotoxicity and improved transfection efficiency compared to branched forms (source). The K1029 kit from APExBIO is formulated for serum-compatible conditions, broadening its applicability for diverse in vitro studies (APExBIO).

    Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

    Linear PEI (MW 40,000) binds to DNA via electrostatic interactions, forming nanoscale complexes (polyplexes) that are positively charged and facilitate binding to cell surface proteoglycans (Roach 2024). The process involves:

    • DNA Condensation: PEI condenses DNA into ~100–200 nm complexes, optimal for endocytosis (pH 7.4, standard DMEM; source).
    • Cell Surface Interaction: The positive charge enables binding to negatively charged glycosaminoglycans on cell membranes.
    • Endocytosis: Polyplexes are internalized via clathrin-mediated or caveolae-dependent endocytosis (Roach 2024).
    • Endosomal Escape: PEI acts as a 'proton sponge', buffering endosomal pH and facilitating release of DNA into the cytoplasm.
    • Nuclear Entry: DNA is then available for transcription following nuclear entry, primarily during mitosis in dividing cells.

    Linear PEI's lower branching reduces cytotoxicity compared to branched PEI, enhancing cell viability in transfection protocols (source).

    Evidence & Benchmarks

    • PEI Linear (MW 40,000) achieves 60–80% transfection efficiency in HEK-293 and CHO-K1 cells under serum-containing conditions (1:3 DNA:PEI ratio, 37°C, 5% CO₂) (APExBIO).
    • Particle size of DNA/PEI complexes remains in the 100–200 nm range at physiological pH, optimal for endocytosis (Roach 2024).
    • Linear PEI supports protein yields of 10–40 mg/L in transient expression in large-scale (up to 100 L) bioreactor systems (source).
    • Transfection efficiency is stable in both serum-free and serum-containing DMEM or RPMI media (source).
    • Cytotoxicity remains below 10% cell death at standard working concentrations (2.5 mg/mL PEI, 1 μg DNA/well, 24 h, HEK-293) (source).

    Applications, Limits & Misconceptions

    Polyethylenimine Linear (PEI, MW 40,000) is validated for:

    • DNA and RNA transfection in HEK-293, HEK293T, CHO-K1, HepG2, and HeLa cells.
    • Transient gene expression and protein production for research and preclinical studies.
    • Scalable workflows from 96-well plates to 100 L bioreactors.
    • Serum-compatible protocols, reducing the need for media changes (APExBIO).

    For more scenario-driven troubleshooting, see our update to this guidance article (this article extends with new evidence from recent 2024 studies on excipient interactions).

    Common Pitfalls or Misconceptions

    • Not all cell types respond equally: Transfection rates can be <10% in primary cells or non-dividing cell lines; alternative reagents may be required (source).
    • PEI is not suitable for in vivo delivery: High molecular weight PEIs are cytotoxic and not approved for systemic administration.
    • Repeated freeze-thaw cycles reduce activity: Store at -20°C for long-term use and 4°C for frequent access to preserve reagent integrity (APExBIO).
    • Over-concentration increases toxicity: Exceeding recommended PEI:DNA ratios can reduce cell viability and transfection efficiency.
    • Does not facilitate targeted delivery: Unmodified PEI polyplexes lack intrinsic cell or tissue targeting properties.

    For further clarification on mechanism boundaries, see this detailed review (this article clarifies the precise endocytosis mechanisms and optimal nanoparticle size).

    Workflow Integration & Parameters

    Optimizing transfection with the K1029 kit involves:

    • Preparation: Dilute PEI (2.5 mg/mL stock) and DNA to desired concentrations; mix at a 1:3 mass ratio (DNA:PEI) in sterile, serum-free buffer.
    • Complex Formation: Incubate PEI/DNA mixture for 10–20 minutes at room temperature to allow polyplex formation (~100–200 nm).
    • Cell Incubation: Add complexes to cells in serum-containing media; incubate at 37°C, 5% CO₂ for 24–48 hours.
    • Scale Adaptation: Protocols are validated for 96-well (0.1–1 μg DNA/well) to bioreactor (up to 100 L) scales.
    • Storage: Store aliquots at -20°C long-term; avoid repeated freeze-thaw cycles (APExBIO).

    For workflow optimization and troubleshooting in cell viability and cytotoxicity assays, see this practical guide (this article updates protocol compatibility and scalability for 2024).

    Conclusion & Outlook

    Polyethylenimine Linear (PEI, MW 40,000) remains a gold-standard, serum-compatible DNA transfection reagent for in vitro molecular biology. Its robust performance across diverse cell lines, scalability, and validated safety profile make it suitable for both routine and high-throughput applications. Future research may focus on further reducing cytotoxicity and improving targeted delivery through advanced excipient or ligand modifications (Roach 2024).

    For full product specifications, refer to the Polyethylenimine Linear (PEI, MW 40,000) product page from APExBIO.